Jul 6, 2023 | Diabetes, MedBen WellLiving, News, Research, Wellness
The growing obesity problem, coupled with an aging population, will more than double the number of people with diabetes in just over 25 years, according to a new study published in the Lancet medical journal. Researchers estimate that worldwide, more than 1.3 million...
Jun 27, 2023 | Asthma, Blood pressure, Cholesterol, Compliance, Diabetes, Hypertension, MedBen WellLiving, Wellness
Did you know that, historically… 76% of all office visits,81% of all inpatient admissions, and91% of all Rx prescriptions … are related to one or more of these chronic conditions? AsthmaCholesterolDiabetesHeart diseaseHypertension However, there is a...
Jun 22, 2023 | Asthma, Diabetes, Diet, Exercise, Heart, Research, Sleep, Vaccinations, Wellness
If sheer volume of analysis is any gauge of interest, then the value of a good night’s sleep is of intense fascination to researchers. In 2023 alone, various studies have suggested that a lack of sleep… Can put you at a higher risk of heart disease.Makes...
Mar 21, 2023 | Brand Name Drugs, Diabetes, Drug costs, Generic Drugs, Insulin, Kurt Harden, MedBen Rx, MedBen University, Pharmacy Benefits Manager (PBM), Prescription
Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing drugmakers Novo Nordisk...
Mar 2, 2023 | Asthma, Cancer, Cholesterol, Cost Savings, Diabetes, Heart, MedBen WellLiving, News, Preventive Care, Primary Care, Reporting, Savings
A new report finds that the primary care workforce has decreased in recent years, and advises that the U.S. should invest more in adding new physicians. It’s a sensible suggestion, considering that primary care has demonstrably contributed to making Americans...
Dec 8, 2022 | Diabetes, Obesity, Prescription
The latest “Hollywood weight-loss drug” has generated interest for its pound-shedding potential, but doctors caution that its benefits should be measured against other factors. Approved by the FDA in 2017 for type 2 diabetes treatment, Semaglutide...
